Lancet calls for transparency in selection of new Executive Director for Global Fund

NewsGuard 100/100 Score

The secrecy surrounding the selection process for the next Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria could irrevocably damage the organisation's ability to improve global health, states an Editorial in this week's issue of The Lancet.

Initial plans for recruiting candidates for the Fund's next Executive Director had promised a fair and transparent process, free of the usual political wrangling that dogs UN appointments. Instead, however, the Global Fund Board's aversion to political campaigning has "resulted in a perverse secrecy pervading the proceedings", the Editorial states.

"Transparency, accountability, and dispassionate independence are the ideals on which the Global Fund most prides itself. It is therefore a perplexing hypocrisy that the selection process for a new Executive Director seems bereft of these values. The Global Fund's Board is right to acknowledge that the circus of political campaigning too often means poorly qualified people being installed in top positions for the wrong reasons. But it is a serious mistake to let this aversion erode its accountability", The Lancet warns.

As things stand, no one will know the names on the ten-person shortlist being discussed by the Global Fund Nomination Committee—an eight-person group comprising mainly Board members—this week.

The Editorial concludes: "To give the Executive Director selection process the credibility it deserves The Lancet calls on Carol Jacobs, chair of the Global Fund's Board, to: 1) make public the shortlist of candidates circulated this week; 2) ask candidates to publish an election platform and declare their intentions for the future of the Fund; and 3) ensure that the Board's deliberations are open to public scrutiny. Anything less would damage irrevocably the Fund's potential to improve global health."

http://www.thelancet.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO releases an investment case for TB screening and preventive treatment